Pure Biologics Statistics

Total Valuation

Pure Biologics has a market cap or net worth of PLN 34.11 million. The enterprise value is 47.85 million.

Market Cap	34.11M
Enterprise Value	47.85M

Important Dates

The last earnings date was Wednesday, April 16, 2025.

Earnings Date	Apr 16, 2025
Ex-Dividend Date	n/a

Share Statistics

Pure Biologics has 3.75 million shares outstanding.

Current Share Class	3.75M
Shares Outstanding	3.75M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.87%
Owned by Institutions (%)	8.60%
Float	2.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-2.60
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.66
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.14

Current Ratio	0.14
Quick Ratio	0.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.31

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-61.72%
Return on Invested Capital (ROIC)	-98.14%
Return on Capital Employed (ROCE)	94.42%
Revenue Per Employee	n/a
Profits Per Employee	-1.56M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.52% in the last 52 weeks. The beta is 1.59, so Pure Biologics's price volatility has been higher than the market average.

Beta (5Y)	1.59
52-Week Price Change	+25.52%
50-Day Moving Average	11.43
200-Day Moving Average	17.04
Relative Strength Index (RSI)	38.15
Average Volume (20 Days)	38,575

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-46,000
Operating Income	-12.38M
Pretax Income	-6.25M
Net Income	-6.25M
EBITDA	-12.08M
EBIT	-12.38M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 313,000 in cash and 14.06 million in debt, giving a net cash position of -13.75 million or -3.67 per share.

Cash & Cash Equivalents	313,000
Total Debt	14.06M
Net Cash	-13.75M
Net Cash Per Share	-3.67
Equity (Book Value)	-13.12M
Book Value Per Share	n/a
Working Capital	-13.35M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.83M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pure Biologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-18.31%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a